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Abstract
Background: We performed a longitudinal study of viral etiology in samples collected in New York City during
May 2009 to May 2010 from outpatients with fever or respiratory disease symptoms in the context of a pilot
respiratory virus surveillance system.
Methods: Samples were assessed for the presence of 13 viruses, including influenza A virus, by MassTag PCR.
Results: At least one virus was detected in 52% of 940 samples analyzed, with 3% showing co-infections. The most
frequently detected agents were rhinoviruses and influenza A, all representing the 2009 pandemic H1N1 strain. The
incidence of influenza H1N1-positive samples was highest in late spring 2009, followed by a decline in summer
and early fall, when rhinovirus infections became predominant before H1N1 reemerged in winter. Our study also
identified a focal outbreak of enterovirus 68 in the early fall of 2009.
Conclusion: MassTag multiplex PCR affords opportunities to track the epidemiology of infectious diseases and may
guide clinicians and public health practitioners in influenza-like illness and outbreak management. Nonetheless, a
substantial proportion of influenza-like illness remains unexplained underscoring the need for additional platforms.
Background
In 2009 an influenza pandemic was precipitated by the
emergence of a novel H1N1 influenza A virus that
represented a reassortant of previously circulating avian,
human and swine viruses [1-5]. The first cases were
reported in March and April 2009, initially from the
Veracruz region of Mexico, immediately followed by
reports from California and Texas in the United States
(US) [6,7]. By late April 2009 over half of the total con-
firmed US cases were from New York City (NYC) [8].
The virus quickly spread globally, with over 17,000 cases
reported from 62 countries by June 1, 2009. In response
to the outbreak, the NYC Department of Health and
Mental Hygiene (DOHMH) implemented an enhanced
citywide influenza surveillance program focusing on
cases of severe influenza and influenza-like illness (ILI)
in hospitals [9]. To enable surveillance in ambulatory
care settings, samples from patients presenting with
fever or respiratory illness were collected in nine com-
munity health care centers over a period of thirteen
months, and analyzed for respiratory viruses by Mas-
sTag PCR, a multiplex molecular platform for diagnostic
microbiology [10-15].
Methods
Nasopharyngeal (NP) swabs were collected at 9 New
York City community health centers of the Institute for
Family Health between May 29, 2009 and May 27, 2010
from patients with fever (>37.7°C) or symptoms of
respiratory infection. Peak numbers were collected within
the first two months of the pandemic and again in fall
and winter, coinciding with the seasonality of ILI in the
northern hemisphere. The study protocol was approved
by the Institutional Review Boards of the DOHMH
(IRB#09-031) and Institute for Family Health and con-
sent was obtained from all patients. Samples were tested
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including influenza A (FLUAV), influenza B (FLUBV),
human rhinoviruses (HRV), human enteroviruses (HEV),
human metapneumovirus (HMPV), human parainfluenza
virus (HPIV) 1-4, human coronaviruses (HCoV) 229E
and OC43, and respiratory syncytial virus (RSV) A and B.
All positive samples were re-amplified by singleplex PCR
for sequence-based typing.
Results
A total of 940 samples were analyzed (Table 1). At least
one agent was detected in 489 samples (52%). The
viruses most commonly detected were influenza A virus
and rhinoviruses at 202 (21%) and 185 (20%), respec-
tively (Figure 1). All influenza A viruses were the 2009
H1N1 pandemic strain (A/H1N1/09) as indicated by
sequence analysis; one sample was positive for influenza
B virus. Influenza A virus was detected in the majority
of samples collected from May through June 2009, and
again during November 2009 to January 2010, whereas
rhinoviruses predominated during August through
October 2009 and February to May 2010, when influ-
enza A virus activity was low (Figure 2). The frequency
of detection of human rhinovirus A, B and C species
varied over the sampling interval (Figure 3). Infections
were more common with rhinovirus A (41%) and rhino-
virus C (39%) than rhinovirus B (20%). In September
2009, 14 samples (23%) were enterovirus-positive.
Sequencing of a 500 base-pair fragment in the VP4/2
gene region indicated that all of these enterovirus-posi-
tive samples represented a single strain of enterovirus
68. The number of samples positive for this virus
declined to six in October. Only four additional entero-
virus-positive samples were obtained during the rest of
the study; three were coxsackievirus A2 and one cox-
sackievirus A6. A total of 30 (3%) of 940 virus samples
had evidence of co-infection with two or more viruses;
14 of these showed co-infection with influenza virus and
rhinovirus (Figure 1). Collectively, influenza viruses and
rhinoviruses accounted for 74% of all viruses detected in
our sample set. Other viruses detected, in order of
decreasing frequency, included HMPV (3%), RSV-A
(2%), HPIV-3 (2%), HCoV-OC43 (1%), HPIV-1 (1%),
RSV-B (1%), HPIV-2 (1%), HCoV-229E (1%), and HPIV-
4 (<1%)(Table 1). The peak activity for HCoV-OC43
occurred during late fall/early winter months, overlap-
ping with the seasonal peak of RSV-A and -B, while the
detection of HMVP, HPIV-A and -3 did not show a sig-
nificant seasonality.
Discussion
Our analysis of respiratory samples from NYC collected
during the first year of the A/H1N1/09 outbreak indi-
cates that the novel recombinant virus had quickly
established itself as the primary circulating influenza
v i r u si nt h ec i t y .N o t a b l y ,a l li n f l u e n z aAv i r u s - p o s i t i v e
samples within the analyzed sample set collected in
community health care centers from symptomatic
patients represented the A/H1N1/09 strain. Reports on
A/H1N1/09 prevalence in 2009/2010 vary from different
areas of the globe. Some indicate that while A/H1N1/09
was the predominant virus in circulation, seasonal influ-
enza nonetheless accounted for approximately 10% of
influenza cases [16]. However, our results are in accord
with a report from the Centers for Disease Control and
Prevention indicating that A/H1N1/09 was responsible
for > 99% of influenza cases in the US between April
2009 and June 2010 [17].
Table 1 Distribution of agents detected in respiratory samples in New York City, May 2009 through May 2010
Total
samples
FLUAV FLUBV HEV HRV HCoV-
OC43
HCoV-229E HMPV HPIV-1 HPIV-2 HPIV-3 HPIV-4 RSVA RSVB
May 24 16 (66%) 0 0 3 (12%) 0 0 1 (4%) 0 0 0 0 0 0
Jun 116 65 (56%) 0 0 18 (16%) 0 1 (1%) 1 (1%) 2 (2%) 1 (1%) 5 (4%) 0 0 0
Jul 16 2 (12%) 0 0 2 (12%) 0 0 0 0 0 4 (25%) 0 0 0
Aug 12 1 (8%) 0 0 2 (16%) 0 0 0 0 0 0 1 (8%) 0 0
Sep 62 3 (5%) 0 14 (23%) 17 (27%) 0 0 1 (2%) 1 (2%) 0 0 0 0 0
Oct 179 18 (10%) 0 8 (4%) 44 (25%) 2 (1%) 0 0 3 (2%) 2 (1%) 1 (<1%) 1 (<1%) 0 0
Nov 137 33 (24%) 0 1 (1%) 22 (16%) 1(1%) 0 2 (1%) 1 (1%) 1 (1%) 0 0 5 (4%) 0
Dec 182 38 (21%) 0 0 40 (22%) 8 (4%) 1 (<1%) 1 (<1%) 1 (<1%) 1 (<1%) 0 0 11 (6%) 2 (1%)
Jan 106 22 (21%) 0 1 (1%) 11 (10%) 2 (2%) 3 (3%) 1 (1%) 1 (1%) 4 (4%) 0 4 (4%) 3 (3%)
Feb 54 1 (2%) 0 0 13 (24%) 0 2 (4%) 12 (22%) 0 0 0 0 0 2(4%)
Mar 37 3 (8%) 0 0 9 (24%) 0 1 (3%) 1 (3%) 1 (3%) 0 1 (3%) 0 0 0
Apr 9 0 1 (10%) 0 2 (22%) 0 1 (10%) 1 (10%) 0 0 1 (10%) 0 0 0
May 6 0 0 0 2 (33%) 0 0 0 0 0 2 (33%) 0 0 0
total 940 202 (21%) 1 (<1%) 24 (3%) 185 (20%) 13 (1%) 6 (1%) 24 (3%) 10 (1%) 6 (1%) 18 (2%) 2 (<1%) 20 (2%) 7 (1%)
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summer and early fall of 2009 may have delayed the ree-
mergence of A/H1N1/09 [18,19] through induction of
innate immunity. Our survey is not inconsistent with
this model. The frequency of A/H1N1/09-positive sam-
ples increased in November, after the peak activity of
rhinovirus in September/October 2009. However,
whether HRV infection influenced A/H1N1/09 re-
appearance is unclear; late summer and early fall is the
seasonal time for rhinovirus circulation and the
observed pattern may thus be coincidental. However,
our finding of a low co-infection rate between the two
agents despite their overall high prevalence over the
course of the study is compatible with an interference of
rhinovirus infection with influenza.
We also identified a high frequency of enterovirus 68
infection in samples collected during September and Octo-
ber. Unlike other enteroviruses, enterovirus 68 has been
predominately associated with respiratory disease, but is
rarely reported in the US [20]. The temporal clustering of
enterovirus 68 positive samples suggests a short, local
outbreak.
Conclusion
This study underscores the importance of unbiased mul-
tiplexed surveillance for the presence of respiratory
pathogens. Through systematic collection of samples
and the application of methods like MassTag PCR we
anticipate new insights into the epidemiology of infec-
tious diseases that will allow prioritization of invest-
ments in vaccines and drugs. We also note that one of
the agents found most commonly in our samples, rhino-
virus C [11-13,21], was unknown as recently as 2006,
and has not yet been cultured. Given that no virus was
identified in close to 50% of the specimens we examined
there is clearly need for additional efforts in pathogen
discovery.
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Figure 1 Summary of virus infections and co-infections with
influenza A virus and human rhinovirus.
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Figure 2 Monthly incidence of influenza A virus, human
rhinovirus and human enterovirus. Each data point is shown as a
percentage of all samples screened during that month.
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Figure 3 Distribution of human rhinovirus A, B, and C detected
in samples from September 2009 to March 2010. Data from
May-Aug 2009 and Apr-May 2010 is not shown due to low number
of rhinovirus-positive samples. Each bar represents the percentage
of all sequenced rhinoviruses detected in that month.
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